Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yueju Pill
- Development stage
- Preclinical
- Lead developer
- Zhu Danxi
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Yueju Pill is a classic Traditional Chinese Medicine (TCM) herbal formula developed over 800 years ago by Zhu Danxi. It consists of five herbs and is primarily used to treat depression-related syndromes and mood disorders. Modern research has demonstrated that Yueju Pill exhibits rapid antidepressant effects comparable to ketamine, likely through the upregulation of brain-derived neurotrophic factor (BDNF) in the hippocampus[1][2][4]. The main active herb responsible for this effect appears to be Gardenia jasminoides Ellis. Beyond its psychiatric uses, recent studies suggest potential benefits in metabolic diseases such as nonalcoholic steatohepatitis (NASH), obesity, and hyperlipidemia by regulating lipid metabolism and protecting hepatocytes[3]. The formula works by promoting Qi movement and releasing various types of stagnation (Qi, Blood, Phlegm, Fire, Food, Dampness)[7][8].
- Brand names
- Yue Ju WanEscape Restraint Pill
- Other names
- Yuè Jū Wán越鞠丸Escape Restraint Pill
02
Targets
ACC (Acetyl-CoA Carboxylase 1)BCL-2 (BCL-2 family)BDNF (Brain-derived neurotrophic factor)
Beyond the preview
Go deeper on Yueju Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yueju Pill.